je.st
news
Tag: cancer
Kroger lights up pink to kick off Breast Cancer Awareness Month
2014-09-30 04:19:30| Grocery - Topix.net
Monday morning, the Kroger headquarters in downtown Cincinnati turned on the pink lights and revealed a 150 foot billboard to kick off their Sharing Courage campaign. It's the fifth year Kroger and Yoplait have partnered to raise money for breast cancer research, detection, treatment and prevention.
Tags: month
pink
cancer
lights
Kroger goes pink to promote breast cancer awareness
2014-09-30 04:19:29| Grocery - Topix.net
Monday morning, the Kroger headquarters in downtown Cincinnati turned on the pink lights and revealed a 150 foot billboard to kick off their Sharing Courage campaign. THE CITY OF FLORENCE, BUT SO FAR THE CITY HAS YET TO RESPOND.
Tags: promote
pink
cancer
awareness
Seattle Genetics and Takeda's cancer drug meets main trial goal
2014-09-29 19:14:26| Biotech - Topix.net
Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Patients who received the drug, Adcetris, immediately after a stem cell transplant, lived significantly longer without the disease progressing than those who were given a placebo, the companies said in a joint statement.
Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014
2014-09-29 11:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. KEYTRUDA monotherapy achieved 24 percent overall response rate in patients with PD-L1 positive, advanced bladder (urothelial) cancer Planned Phase 3 study in advanced bladder cancer to be initiated by the end of 2014 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA (pembrolizumab) the companys anti-PD-1 therapy in PD-L1 positive, advanced urothelial cancer (also known as bladder cancer). Language: English Contact: MerckMedia:Ian McConnell, 973-901-5722Claire Mulhearn, 908-423-7425orInvestor:Joseph Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
data
advanced
early
Merck drug extends immune system fight to stomach cancer
2014-09-28 15:10:51| Biotech - Topix.net
Merck & Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows. Early clinical trial results reported on Sunday mean that gastric, or stomach cancer can be added to a growing list of tumor types where so-called immunotherapy may have an important role to play.
Tags: system
drug
fight
cancer
Sites : [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] next »